Whole-Genome Gene Expression Profiling of Formalin-Fixed, Paraffin-Embedded Tissue Samples

Background We have developed a gene expression assay (Whole-Genome DASL®), capable of generating whole-genome gene expression profiles from degraded samples such as formalin-fixed, paraffin-embedded (FFPE) specimens. Methodology/Principal Findings We demonstrated a similar level of sensitivity in gene detection between matched fresh-frozen (FF) and FFPE samples, with the number and overlap of probes detected in the FFPE samples being approximately 88% and 95% of that in the corresponding FF samples, respectively; 74% of the differentially expressed probes overlapped between the FF and FFPE pairs. The WG-DASL assay is also able to detect 1.3–1.5 and 1.5–2 -fold changes in intact and FFPE samples, respectively. The dynamic range for the assay is ∼3 logs. Comparing the WG-DASL assay with an in vitro transcription-based labeling method yielded fold-change correlations of R2 ∼0.83, while fold-change comparisons with quantitative RT-PCR assays yielded R2∼0.86 and R2∼0.55 for intact and FFPE samples, respectively. Additionally, the WG-DASL assay yielded high self-correlations (R2>0.98) with low intact RNA inputs ranging from 1 ng to 100 ng; reproducible expression profiles were also obtained with 250 pg total RNA (R2∼0.92), with ∼71% of the probes detected in 100 ng total RNA also detected at the 250 pg level. When FFPE samples were assayed, 1 ng total RNA yielded self-correlations of R2∼0.80, while still maintaining a correlation of R2∼0.75 with standard FFPE inputs (200 ng). Conclusions/Significance Taken together, these results show that WG-DASL assay provides a reliable platform for genome-wide expression profiling in archived materials. It also possesses utility within clinical settings where only limited quantities of samples may be available (e.g. microdissected material) or when minimally invasive procedures are performed (e.g. biopsied specimens).

[1]  M. Monden,et al.  Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples. , 1999, Nucleic acids research.

[2]  S. Sealfon,et al.  Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays. , 2002, Nucleic acids research.

[3]  D. Geschwind,et al.  An evaluation of tyramide signal amplification and archived fixed and frozen tissue in microarray gene expression analysis. , 2002, Nucleic acids research.

[4]  Aaron Bouchie,et al.  Coming soon: a global grid for cancer research , 2004, Nature Biotechnology.

[5]  Jian-Bing Fan,et al.  Tumorigenesis and Neoplastic Progression Quantitative Gene Expression Profiling in Formalin-Fixed , Paraffin-Embedded Tissues Using Universal Bead Arrays , 2004 .

[6]  Sridhar Ramaswamy,et al.  Translating cancer genomics into clinical oncology. , 2004, The New England journal of medicine.

[7]  Philippe Rigault,et al.  A novel, high-performance random array platform for quantitative gene expression profiling. , 2004, Genome research.

[8]  Jian-Bing Fan,et al.  A versatile assay for high-throughput gene expression profiling on universal array matrices. , 2004, Genome research.

[9]  J. Wang-Rodriguez,et al.  Gene expression profiles in formalin-fixed, paraffin-embedded tissues obtained with a novel assay for microarray analysis. , 2004, Clinical chemistry.

[10]  S. Paik,et al.  Technology Insight: application of molecular techniques to formalin-fixed paraffin-embedded tissues from breast cancer , 2005, Nature Clinical Practice Oncology.

[11]  Albert Zlotnik,et al.  Effects of RNA degradation on gene expression analysis of human postmortem tissues , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  R. Boyce,et al.  Preliminary Comparison of Quantity, Quality, and Microarray Performance of RNA Extracted From Formalin-fixed, Paraffin-embedded, and Unfixed Frozen Tissue Samples , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[13]  Barbara A. Murphy,et al.  Gene Expression Profiles Identify Epithelial-to-Mesenchymal Transition and Activation of Nuclear Factor-κB Signaling as Characteristics of a High-risk Head and Neck Squamous Cell Carcinoma , 2006 .

[14]  Yajun Yi,et al.  Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma. , 2006, Cancer research.

[15]  Christina L. Zheng,et al.  Two-dimensional transcriptome profiling: identification of messenger RNA isoform signatures in prostate cancer from archived paraffin-embedded cancer specimens. , 2006, Cancer research.

[16]  Vladimir Makarov,et al.  Whole transcriptome amplification for gene expression profiling and development of molecular archives. , 2006, Neoplasia.

[17]  J. Eliason,et al.  Transcriptional profiling of degraded RNA in cryopreserved and fixed tissue samples obtained at autopsy , 2006, BMC clinical pathology.

[18]  S. Paik Methods for Gene Expression Profiling in Clinical Trials of Adjuvant Breast Cancer Therapy , 2006, Clinical Cancer Research.

[19]  F. Couch,et al.  Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer. , 2007, Journal of the National Cancer Institute.

[20]  F. Medeiros,et al.  Tissue handling for genome-wide expression analysis: a review of the issues, evidence, and opportunities. , 2007, Archives of pathology & laboratory medicine.

[21]  R. Stoyanova,et al.  Successful application of microarray technology to microdissected formalin-fixed, paraffin-embedded tissue. , 2007, The Journal of molecular diagnostics : JMD.

[22]  Stefanie S Jeffrey,et al.  Bmc Molecular Biology Rna Extraction from Ten Year Old Formalin-fixed Paraffin-embedded Breast Cancer Samples: a Comparison of Column Purification and Magnetic Bead-based Technologies , 2022 .

[23]  F. Couch,et al.  Response: Re: Molecular Basis for Estrogen Receptor α Deficiency in BRCA1-Linked Breast Cancer , 2007 .

[24]  C. Perou,et al.  RNA expression analysis of formalin-fixed paraffin-embedded tumors , 2007, Laboratory Investigation.

[25]  J. Wang-Rodriguez,et al.  Expression signatures that correlated with Gleason score and relapse in prostate cancer. , 2007, Genomics.

[26]  J. Timmer,et al.  A novel approach for reliable microarray analysis of microdissected tumor cells from formalin-fixed and paraffin-embedded colorectal cancer resection specimens , 2009, Journal of Molecular Medicine.

[27]  Thomas D. Wu,et al.  Microarray analysis of RNA extracted from formalin-fixed, paraffin-embedded and matched fresh-frozen ovarian adenocarcinomas , 2009, BMC Medical Genomics.

[28]  D. Cimino,et al.  Quantitative expression profiling of highly degraded RNA from formalin-fixed, paraffin-embedded breast tumor biopsies by oligonucleotide microarrays , 2008, Laboratory Investigation.

[29]  Brian Leyland-Jones,et al.  Optimization of RNA extraction from FFPE tissues for expression profiling in the DASL assay. , 2008, BioTechniques.

[30]  Yanxiang Cao,et al.  Tissue handling and specimen preparation in surgical pathology: issues concerning the recovery of nucleic acids from formalin-fixed, paraffin-embedded tissue. , 2009, Archives of pathology & laboratory medicine.

[31]  Y. Asmann,et al.  A Tissue Biomarker Panel Predicting Systemic Progression after PSA Recurrence Post-Definitive Prostate Cancer Therapy , 2008, PloS one.

[32]  Timothy Hunter,et al.  Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer , 2009, Breast Cancer Research and Treatment.

[33]  Kenji Ikeda,et al.  Gene expression in fixed tissues and outcome in hepatocellular carcinoma. , 2008, The New England journal of medicine.

[34]  Richard D. Kennedy,et al.  RNA expression analysis from formalin fixed paraffin embedded tissues , 2008, Histochemistry and Cell Biology.

[35]  R. Eeles,et al.  TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer , 2008, British Journal of Cancer.

[36]  J Denton,et al.  Acquisition of biologically relevant gene expression data by Affymetrix microarray analysis of archival formalin-fixed paraffin-embedded tumours , 2008, British Journal of Cancer.

[37]  T. Golub,et al.  Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. , 2008, Journal of the National Cancer Institute.

[38]  Jian-Bing Fan,et al.  Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer. , 2009, Gynecologic oncology.

[39]  Crispin J. Miller,et al.  Methods comparison for high-resolution transcriptional analysis of archival material on Affymetrix Plus 2.0 and Exon 1.0 microarrays. , 2009, BioTechniques.